08:41 AM EDT, 06/17/2024 (MT Newswires) -- Qiagen ( QGEN ) said Monday it aims to achieve 7% annual sales growth until 2028 and targets a 31% adjusted operating income margin in 2028.

The diagnostic services provider said it plans to streamline operations by focusing on key products like its PCR-based genetic testing machines, diagnostic tests for cancer and infectious diseases, analytical software, and a tuberculosis blood test.

Qiagen ( QGEN ) said it will present its plans at an investor event at noon ET.

Price: 42.47, Change: +0.13, Percent Change: +0.31